SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-17-044421
Filing Date
2017-07-11
Accepted
2017-07-11 10:27:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-16006_1sc13ga.htm SC 13G/A 69675
  Complete submission text file 0001104659-17-044421.txt   71163
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Subject) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85368 | Film No.: 17959270
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6-15, OTSUKA 5-CHOME, BUNKYO-KU TOKYO M0 112-8650
Business Address 6-15, OTSUKA 5-CHOME, BUNKYO-KU TOKYO M0 112-8650 81-3-3946-1111
Zenyaku Kogyo Co., Ltd. (Filed by) CIK: 0001630202 (see all company filings)

IRS No.: 980336168 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13G/A